Biomarker for detecting esophagus cancer
A biomarker, esophageal cancer technology, applied in the field of tumor markers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0080] Example 1 Mass Spectrometry Detection of Esophageal Cancer Serum Polypeptides and Establishment of Esophageal Cancer Screening Model
[0081] 1. Samples and instruments:
[0082] Serum samples were selected from 397 cases, of which 201 were from patients with esophageal cancer and the other 196 were from healthy people. All patients with esophageal cancer were diagnosed as esophageal squamous cell carcinoma by postoperative pathological reports. All serum samples were taken in the morning on an empty stomach, and the serum was separated and stored in a -80°C low-temperature refrigerator.
[0083] Matrix-assisted laser desorption time-of-flight mass spectrometry Clin-TOF (Yixing Industry (Beijing) Technology Co., Ltd.) and the experimental WCX magnetic bead kit (SPE-C magnetic bead kit, see Chinese patent ZL2008101879684) were developed by Yixing Industry Company . The analysis processing of data can adopt the software commonly used in this field, for example the Clinp...
Embodiment 2
[0119] Example 2 Blind selection test of esophageal cancer screening model
[0120] 198 of 397 serum samples (201 from patients with esophageal cancer and 196 from healthy people) were randomly selected as training samples for the establishment of the model, 100 of which were from patients with esophageal cancer, including 24 cases of early esophageal cancer ( TNM stage I), and the other 98 cases were from healthy people; patients with esophageal cancer were confirmed by postoperative pathological reports. All serum samples were taken in the morning on an empty stomach, and the serum was separated and stored in a -80°C low-temperature refrigerator.
[0121] Another 199 remaining samples were selected as verification samples for blind selection testing, among which 101 were known to be from patients with esophageal cancer, including 19 cases of early-stage esophageal cancer (TNM stage I), and the other 98 were from healthy people. The processing method is the same as above.
...
Embodiment 3
[0132] Example 3 TSP1 protein can be used to distinguish esophageal squamous cell carcinoma and normal population at the tissue level
[0133] The identified thrombospondin 1 (TSP1) polypeptide fragment (2950.6m / z) was highly expressed in the serum of patients with esophageal squamous cell carcinoma (ESCC). In order to detect the expression of TSP1 in tissues, we carried out Immunohistochemical detection.
[0134] Anti-TSP1 antibody (Cat. No. 18304-1-AP, ProteintechGroup Inc., IL, USA) was used to detect the tissue chip (Shanghai Xinchao Biotechnology Co., Ltd., lot No. -Squ172Sur-01) for staining. The enhanced one-step Polymer detection system (Beijing Zhongshan Jinqiao Biotechnology Co., Ltd., Cat. No. PV-6001) was used for staining. The tissue chip was dewaxed with xylene, hydrated with graded ethanol, and immersed in 30 mL / L H 2 o 2 10 min to block endogenous peroxidase activity. After the slices were washed with PBS, they were placed in a 0.01 mol / L, pH 6.0 citrate bu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com